2022年12月最新中科院JCR期刊分区表数据（升级版）已经更新，欢迎查询！ 如果您对期刊系统有任何需求或者问题，欢迎反馈给我们。
 |
| 基本信息 | 登录收藏 | |||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名字 | EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY EUR J MED CHEM LetPub评分 8.0
60人评分
我要评分
声誉 8.8 影响力 7.2 速度 9.1 | |||||||||||||||||||||||||
| 期刊ISSN | 0223-5234 | 微信扫码收藏此期刊 | ||||||||||||||||||||||||
| E-ISSN | 1768-3254 | |||||||||||||||||||||||||
| 2021-2022最新影响因子 （数据来源于搜索引擎） | 注册或登录后，查看影响因子和历年趋势图 | |||||||||||||||||||||||||
| 2021-2022自引率 | 9.60%注册或登录后，查看自引率趋势图 | |||||||||||||||||||||||||
| h-index | 135 | |||||||||||||||||||||||||
| CiteScore |
| |||||||||||||||||||||||||
| 期刊简介 | The European Journal of Medicinal Chemistry is a global journal that publishes studies on all aspects of medicinal chemistry. It provides a medium for publication of original papers and also welcomes critical review papers. A typical paper would report on the organic synthesis, characterization and pharmacological evaluation of compounds. Other topics of interest are drug design, QSAR, molecular modeling, drug-receptor interactions, molecular aspects of drug metabolism, prodrug synthesis and drug targeting. The journal expects manuscripts to present the rational for a study, provide insight into the design of compounds or understanding of mechanism, or clarify the targets. | |||||||||||||||||||||||||
| 期刊官方网站 | http://www.elsevier.com/wps/find/journaldescription.cws_home/505813/description | |||||||||||||||||||||||||
| 期刊投稿网址 | https://www.editorialmanager.com/EJMECH | |||||||||||||||||||||||||
| 是否OA开放访问 | No | |||||||||||||||||||||||||
| 通讯方式 | ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER, 23 RUE LINOIS, PARIS, FRANCE, 75724 | |||||||||||||||||||||||||
| 出版商 | Elsevier Masson SAS | |||||||||||||||||||||||||
| 涉及的研究方向 | 化学-医药化学 | |||||||||||||||||||||||||
| 出版国家或地区 | FRANCE | |||||||||||||||||||||||||
| 出版语言 | Multi-Language | |||||||||||||||||||||||||
| 出版周期 | Monthly | |||||||||||||||||||||||||
| 出版年份 | 0 | |||||||||||||||||||||||||
| 年文章数 | 916注册或登录后，查看年文章数趋势图 | |||||||||||||||||||||||||
| Gold OA文章占比 | 3.36% | |||||||||||||||||||||||||
| 研究类文章占比： 文章 ÷（文章 + 综述） | 82.64% | |||||||||||||||||||||||||
| WOS期刊SCI分区 （ 2021-2022年最新版） | WOS分区等级：1区
| |||||||||||||||||||||||||
| 中科院《国际期刊预警 名单（试行）》名单 | 2021年12月发布的2021版：不在预警名单中 2021年01月发布的2020版：不在预警名单中 | |||||||||||||||||||||||||
| 中科院SCI期刊分区 （ 2022年12月最新升级版） | 注册或登录后，查看中科院SCI期刊分区趋势图
| |||||||||||||||||||||||||
| 中科院SCI期刊分区 （ 2021年12月基础版） |
| |||||||||||||||||||||||||
| 中科院SCI期刊分区 （ 2021年12月升级版） |
| |||||||||||||||||||||||||
| 中科院SCI期刊分区 （ 2020年12月旧的升级版） |
| |||||||||||||||||||||||||
| SCI期刊收录coverage | Science Citation Index Expanded (SCIE) (2020年1月，原SCI撤销合并入SCIE，统称SCIE) Scopus (CiteScore) | |||||||||||||||||||||||||
| PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=0223-5234%5BISSN%5D | |||||||||||||||||||||||||
| 平均审稿速度 | 网友分享经验： 平均4.3个月 来源Elsevier官网： 平均7.4周 | |||||||||||||||||||||||||
| 平均录用比例 | 网友分享经验： 较易 来源Elsevier官网： 32% | |||||||||||||||||||||||||
| 在线出版周期 | 来源Elsevier官网： 平均3.7周 | |||||||||||||||||||||||||
| 期刊常用信息链接 | ||||||||||||||||||||||||||
|
|
| |
| 注册或登录后，查看自引率趋势图 |
| 注册或登录后，查看中科院SCI期刊分区趋势图 |
| 注册或登录后，查看年文章数趋势图 |
| 中国学者近期发表的论文 | |
| 1. | Structure-activity relationship (SAR) studies of synthetic glycogen synthase kinase-3β inhibitors: A critical review Author: M. Xu, S.L. Wang, L. Zhu, P.Y. Wu, W.B. Dai, K.P. Rakesh Journal: EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2019, Vol.164, 448-470, DOI:10.1016/j.ejmech.2018.12.073 DOI |
| 2. | Exploration of novel macrocyclic dipeptide N-benzyl amides as proteasome inhibitors Author: Jianjun Yu, Jieyu Liu, Daqiang Li, Lei Xu, Duidui Hong, Shan Chang, Lei Xu, Jia Li, Tao Liu, Yubo Zhou Journal: EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, Vol.164, 423-439, DOI:10.1016/j.ejmech.2018.12.072 DOI |
| 3. | Synthesis and antitubercular evaluation of reduced lipophilic imidazo[1,2-a]pyridine-3-carboxamide derivatives Author: Hongjian Wang, Apeng Wang, Jian Gu, Lei Fu, Kai Lv, Chao Ma, Zeyu Tao, Bin Wang, Mingliang Liu, Huiyuan Guo, Yu Lu Journal: EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, Vol.165, 11-17, DOI:10.1016/j.ejmech.2018.12.071 DOI |
| 4. | Discovery of novel anti-angiogenesis agents. Part 9: Multiplex inhibitors suppressing compensatory activations of RTKs Author: Yuanyuan Shan, Ru Si, Jin Wang, Qingqing Zhang, Huaxin Zhou, Jie Song, Jie Zhang, Qinhua Chen Journal: EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, Vol.164, 440-447, DOI:10.1016/j.ejmech.2018.12.067 DOI |
| 5. | Discovery of first-in-class thiazole-based dual FFA1/PPARδ agonists as potential anti-diabetic agents Author: Zheng Li, Yueming Chen, Zongtao Zhou, Liming Deng, Yawen Xu, Lijun Hu, Bing Liu, Luyong Zhang Journal: EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, Vol.164, 352-365, DOI:10.1016/j.ejmech.2018.12.069 DOI |
| 6. | Discovery of 2-substituted-N-(3-(3,4-dihydroisoquinolin-2(1H)-yl)-2-hydroxypropyl)-1,2,3,4-tetrahydroisoquinoline-6-carboxamide as potent and selective protein arginine methyltransferases 5 inhibitors: Design, synthesis and biological evaluation Author: Jingwei Shao, Kongkai Zhu, Daohai Du, Yuanyuan Zhang, Hongrui Tao, Zhifeng Chen, Hualiang Jiang, Kaixian Chen, Cheng Luo, Wenhu Duan Journal: EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, Vol.164, 317-333, DOI:10.1016/j.ejmech.2018.12.065 DOI |
| 7. | Covalent docking modelling-based discovery of tripeptidyl epoxyketone proteasome inhibitors composed of aliphatic-heterocycles Author: Xiao-Wu Dong, Jian-Kang Zhang, Lei Xu, Jin-Xin Che, Gang Cheng, Xiao-Bei Hu, Li Sheng, An-Hui Gao, Jia Li, Tao Liu, Yong-Zhou Hu, Yu-Bo Zhou Journal: EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, Vol.164, 602-614, DOI:10.1016/j.ejmech.2018.12.064 DOI |
| 8. | Optimization of novel benzofuro[3,2-b]pyridin-2(1H)-one derivatives as dual inhibitors of BTK and PI3Kδ Author: Linyi Liu, Xinyu Li, Yu Cheng, Lianjian Wang, Huizhu Yang, Jiurong Li, Siying He, shuangjie Wu, Qianqian Yin, Hua Xiang Journal: EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, Vol.164, 304-316, DOI:10.1016/j.ejmech.2018.12.055 DOI |
| 9. | Triptolide-targeted delivery methods Author: Hongtao Xu, Bo Liu Journal: EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, Vol.164, 342-351, DOI:10.1016/j.ejmech.2018.12.058 DOI |
| 10. | ONS-donor ligand based Pt(II) complexes display extremely high anticancer potency through autophagic cell death pathway Author: Faiz-Ur Rahman, Amjad Ali, Hong-Quan Duong, Inam Ullah Khan, Muhammad Zeeshan Bhatti, Zhan-Ting Li, Hui Wang, Dan-Wei Zhang Journal: EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, Vol.164, 546-561, DOI:10.1016/j.ejmech.2018.12.052 DOI |
|
|
  | |
|
以上SCI期刊相关数据和信息来源于网络，仅供参考。
投稿状态统计： 我要评分： | |
同领域作者分享投稿经验：共42条 （包含回复） |
我来分享 |
|
|
联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们
© 2010-2023 中国: LetPub上海分公司 网站备案号：沪ICP备10217908号-1 
沪公网安备号：31010402006960
增值电信业务经营许可证：沪B2-20211595
礼翰商务信息咨询（上海）有限公司 办公地址：上海市徐汇区漕溪北路88号圣爱大厦2103室
United States: Tel: 1-781-202-9968 Address: 400 5th Ave, Suite 530, Waltham, Massachusetts 02451
安全保密
